Will Rutland, MD, JD, MPH. Assistant Professor and Psychiatry Clerkship Director, UAB Heersink, School of Medicine, Montgomery Regional Campus. Montgomery, AL.
Dr. Rutland, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Barnes Clayton, MD. Dr. Barnes, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Lydia Bartholow, DNP, PMHNP, CARN-AP
Medical Director, Central City Concern, Portland, OR. Assistant professor, University of California at San Francisco, San Francisco, CA.
Dr. Bartholow, expert for this educational activity, has no financial relationship(s) with ineligible companies to disclose.
Ismene Petrakis, MD
Addiction psychiatrist and professor at Yale School of Medicine. Chief of Mental Health, VA Connecticut Healthcare System, New Haven, CT.
Dr. Petrakis has disclosed that she participated in a study in which she did not receive any compensation from Alkermes apart from medication and Alkermes did not fund the study. Dr. Capurso has reviewed this material and found no evidence of bias pertaining to this educational activity.
Ramon Bataller, MD
Chief of Hepatology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Dr. Bataller has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
